Nearly 80% of adults with a previous SARS-CoV-2 infection demonstrated a loss of smell up to 2 years later, according to a ...

In a recent observational study published in the journal Immunity, researchers from the United States of America investigated the longevity of antibody responses to severe acute respiratory syndrome ...

Health authorities in a central Chinese city on Saturday reported the country's first death from a new type of coronavirus, ...

Prior COVID-19 infection was not independently associated with an increased risk for upper respiratory tract infections in adults.

A recent Lancet Microbe study explores intrahost evolution and the risk factors associated with prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in immunocompromised ...

A new study suggests that a father’s COVID-19 infection could do more than make him sick – it may leave marks on his sperm ...

What if scientists could build a realistic model of the human lung, not full-sized, but grown in the lab from living cells?

Authors propose enhancing awareness of risks, close genomic surveillance and early diagnostic tests for symptomatic contacts as part of clinical management of these patients. *Please mention the ...

A broadly protective sarbecovirus vaccine could have prevented up to 78% of COVID-19 deaths, according to new modelling, and may be key to future pandemic response.

FORT LAUDERDALE, FL / ACCESS Newswire / October 9, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a ...